Genentech Avastin Fails To Meet Primary End Point In Phase III Trial

Genentech, a wholly owned member of the Roche Group, has presented the results of a Phase III trial led by the US Cancer and Leukemia Group B (CALGB) and sponsored by the National Cancer Institute (NC...

Published: 12-Mar-2010

Pfizer Discontinues Phase 3 Study Of Figitumumab

Pfizer has discontinued Phase 3 trial of A4021018 (ADVIGO 1018) examining the effects of investigational compound figitumumab (CP-751,871) in combination with erlotinib as a second/third-line treatmen...

Published: 12-Mar-2010

BioSante Reports Positive Results Of Clinical Study On Leukemia Vaccine

BioSante Pharmaceuticals has declared positive results of a human clinical study that demonstrate that GVAX Leukemia vaccine may be able to diminish or eliminate the last remaining cancer cells in som...

Published: 11-Mar-2010

Baxter International Presents Phase III Study Of Seasonal Flu Vaccine

Baxter International, in partnership with DynPort Vaccine Company, has reported Phase III study data measuring the clinical performance for Preflucel, a trivalent seasonal influenza candidate vaccine....

Published: 11-Mar-2010

Bristol-Myers Squibb Initiates SAVOR-TIMI 53 Trial Of Onglyza

Bristol-Myers Squibb has initiated ‘Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus’ trial (SAVOR-TIMI 53), to evaluate treatment with Onglyza (saxagliptin), a ...

Published: 10-Mar-2010

Cempra Pharma Completes Phase 1 Studies For CEM-101

Cempra Pharma, a privately-held, clinical-stage pharmaceutical firm focused on developing antibacterials, has completed Phase 1 clinical trials of its oral formulation of CEM-101 and also revealed its...

Published: 10-Mar-2010

Limerick BioPharma Reports Positive Results Of Phase 1a Study On LIM-0705

Limerick BioPharma, a developer of therapies that help cells pump unwanted or toxic substances away from vulnerable tissues, has declared positive results of a Phase 1a trial for its lead compound LIM...

Published: 10-Mar-2010

Novavax Completes Enrollment Of Subjects For H1N1 Influenza Vaccine Clinical Trial In Mexico

Novavax, a Maryland-based clinical-stage biotechnology company, has completed the enrollment of over 3,500 subjects in Mexico in Stage B of its 2009 H1N1 virus-like-particle (VLP) pandemic influenza v...

Published: 09-Mar-2010

Roche, Biogen Idec To Terminate Ocrelizumab Treatment

Roche and Biogen Idec have decided to suspend Ocrelizumab treatment of patients in the rheumatoid arthritis (RA) programme. The decision follows the recommendation of the independent Ocrelizumab RA & ...

Published: 08-Mar-2010

AstraZeneca Reports Top-line Results Of Phase II/III Study Evaluating Recentin

AstraZeneca has reported top-line results of a Phase II/III study evaluating Recentin (cediranib) compared with Avastin (bevacizumab) in patients with first-line metastatic colorectal cancer (mCRC). ...

Published: 08-Mar-2010

more news...